Because constitutively increased LXRα expression (Fig 5, A) and activity contributed to IPF fibroblast phenotype, we investigated whether this was caused by altered serum concentrations of LXRα oxysterol ligands in patients with IPF or by altered miR-155 expression. The gene discussed is NR1H3; the disease is idiopathic pulmonary fibrosis.